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Abstract.  Dystrophin deficiency in skeletal muscle of 
the x-linked dystrophic (mdx) mouse can be partially 
remedied by implantation  of normal muscle precursor 
cells (mpc) (Partridge,  T. A., J.  E.  Morgan,  G. R. 
Coulton, E.  P. Hoffman, and L.  M.  Kunkel.  1989. 
Nature  (Lond.).  337:176-179).  However, it is difficult 
to determine whether this biochemical "rescue" results 
in any improvement in the structure or function of the 
treated muscle, because the vigorous regeneration of 
mdx muscle more than compensates for the degenera- 
tion (Coulton,  G. R., N. A.  Curtin,  J. E.  Morgan, 
and T.  A. Partridge.  1988.  Neuropathol.  Appl.  Neu- 
robiol.  14:299-314).  By using x-ray irradiation  to pre- 
vent mpc proliferation,  it is possible to study loss of 
mdx muscle fibers without the complicating effect of 
simultaneous fiber regeneration.  Thus,  improvements 
in fiber survival resulting  from any potential therapy 
can be detected easily (Wakeford, S.,  D. J.  Watt, and 
T.  A. Partridge.  1990.  Muscle  & Nerve.) 
Here, we have implanted normal mpc, obtained 
from newborn mice, into such preirradiated mdx mus- 
cles, finding that it is far more extensively permeated 
and replaced by implanted mpc than is nonirradiated 
mdx muscle; this is evident both from analysis of 
glucose-6-phosphate isomerase isoenzyme markers and 
from immunoblots and immunostaining  of dystrophin 
in the treated muscles. Incorporation of normal mpc 
markedly reduces the loss of muscle fibers and the de- 
terioration of muscle structure which otherwise occurs 
in irradiated  mdx muscles.  Surprisingly,  the regener- 
ated fibers are largely peripherally nucleated, whereas 
regenerated mouse skeletal muscle fibers are normally 
centrally nucleated.  We attribute this regeneration of 
apparently normal muscle to the tendency of newborn 
mouse mpc to recapitulate their neonatal ontogeny, 
even when grafted into 3-wk-old degenerating muscle. 
I 
MPLANTATION of myogenic cells into skeletal  muscles 
of animals  suffering  from recessively inherited  myo- 
pathies has been conducted largely with a view to de- 
veloping methods of tberapy in man (Law et al., 1988; Mor- 
gan et al., 1988; Partridge et al., 1989; Karpati et al., 1989; 
Watt et al.,  1982,  1984).  For the demonstration  of "bio- 
chemical rescue" by implantation  of muscle precursor cells 
(mpc) t  from  normal  mice,  the  dystrophin-deficient  mdx 
mouse (Bulfield  et al.,  1984;  Hoffman  et al.,  1987)  has 
proven most useful; the extent of replacement of the missing 
gene product being verified quantitatively  on immunoblots 
and  histologically  by  immunostaining  (Partridge  et  al., 
1989).  Up to 30% of fibers in treated muscles were con- 
verted from dystrophin negative to dystrophin positive. Nor- 
rnal human myoblasts can also fuse with mdx muscle in vivo 
and synthesize  dystrophin in a  small  percentage of fibers 
(Karpati  et al.,  1989). 
Despite its genetic and biochemical homology to Ducherme 
1. Abbrt~ations used in this paper: DMD, Duchenne muscular dystrophy; 
EDL,  extensor  digitorum  longus;  GPI,  glucose  phosphate  isomerase; 
MPC,  muscle precursor cells; TA,  tibialis anterior; X  irradiation,  x-ray 
irradiation. 
muscular dystrophy (DMD) (Hoffman et al., 1987), the mdx 
mouse has limitations as a model of this disease. As in DMD 
subjects, the mdx mouse suffers widespread degeneration  of 
its skeletal  muscle fibers. This is most striking  between 20 
and 100 d hut persists, less conspicuously, throughout its life 
(Carnwath and Shotton, 1987; Coulton et al., 1988a).  How- 
ever, the counterbalance of regenerating  new fibers results in 
an animal never severely weakened and eventually growing 
larger  and  stronger  than  the wild-type (Anderson  et al., 
1987; Coulton et al.,  1988b). 
To convert the mdx mouse into a model where we Can 
evaluate any potential therapy in terms of improved muscle 
fiber survival, we have inhibited the regeneration  of its mus- 
cle by applying  local high doses of x rays 0Vakeford et al., 
1990).  The resulting  failure  to replace degenerating  fibers 
leads to atrophy and to histological disorganization  as the 
few surviving fibers lose their normal close-packed fascicu- 
lar arrangement  and become progressively separated by a 
loose cellular connective tissue. Here, we show that the in- 
corporation of wild-type neonatal mpc into such preirradi- 
ated mdx muscle counteracts this  massive fiber loss and 
leads to the retention  of an almost normal histological  ap- 
pearance. 
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Strains of  Mouse 
As hosts, we used mdx nude mice, which were derived as described previ- 
ously (Partridge et al.,  1989).  These were of Gpi-ls' allotype.  As mpe 
donors,  we  used newborn  normal  mice of C57BI/10ScSn  or C57BI/6J 
strains, or C57B1/10 mdx mice, all of Gpi-ls  b allotype. 
X-ray Irradiation 
16-d-old mdx nu/nu mice were anesthetized (Watt et al.,  1982) and their 
right legs were subjected to 18 Grays of x-ray irradiation (X irradiation), 
the rest of the body being protected by a 3-ram-thick lead shield (Wakeford 
et ai.,  1990). 
Cell Implantation 
Muscle cells for implantation were prepared by enzymatic disnggregetion 
of neonatal mouse muscle (Watt et al.,  1982), and pellets containing 5  × 
105 cells were prepared.  This is a mixture of myogenic and nonmyogenic 
cells (Morgan, 1988). Between 3 and 5 d after irradiation, host mice were 
anesthetized and an incision was made in the skin overlying the tibialis an- 
terior (TA) muscle of the right leg. Cell pellets were taken up into the tip 
of a 5-#1 Hamilton syringe which was inserted at a shallow angle along the 
length of the muscle and withdrawn as the contents were expelled. The TA 
and the extensor digitorum longus (EDL) muscles were each injected with 
3-5 td of culture medium containing 5  ×  105 cells or, as a control, of cni- 
ture medium alone, in a single injection site. The skin was then closed with 
fine sutures. 
Wild-type C57B1/10 muscle cells were injected into five mice 3 d after 
X irradiation and wild-type C57BI/6J muscle cells were injected into four 
mice 4 d after X irradiation. Medium alone was injected into four mice 3 d 
after X irradiation and mdx muscle cells were injected into three mice 5 d 
after X irradiation. This age, 19-21 d, was chosen such that the mdx muscle 
should be about to undergo massive necrosis (Coulton et al.,  1988a). 
Analysis of  Muscles 
The TA, EDL, and peroneus muscles were removed from the irradiated and 
contraiateral (control) legs at 7, 10, 14, 21, 29, 49, and 67 d after the implan- 
tation of cells or medium. The muscles of the right leg and of seven of the 
left legs were bisected transversely. The proximal half was mounted in Tis- 
sue Tec OTC compound and frozen in isopentane cooled to -165"C in liq- 
uid nitrogen. The distal half was fixed in formalin and processed for wax 
histology. For the remaining left legs, only wax histology of the distal halves 
of the muscles was examined. 
Three 5-•m-eryostat  sections, spaced 100 t~m apart, were cut from each 
of  the  muscles  into  which  rope  had  been  implanted.  The  glucose-6- 
phosphate isomerase (EC 53  1 9; GPI) isoenzymes from one section, at 
each level, were separated by IEF and visualized (Morgan et al., 1987). The 
remaining sections were stained with haemotoxylin and eosin for histologi- 
cal examination. The relative proportions of donor and heterodimer GPI 
were estimated by rettectance-scanning photographs of the separated GPI 
iseenzymes on a Shimadzu dual wavelength TLC scanner. Absolute quanti- 
tation is made unreliable by multiple banding of each GPI isozyme in IEF 
gels and by the problem of ensuring photography in the linear phase of de- 
velopment of the staining reaction. However, the scans do give reliable ordi- 
nal data on the relative activities of the isomers present in a given section. 
This in turn is a good sample of average host/donor composition of the mus- 
cle as a whole (Peterson and Pena, 1984). 8-t~m-thick eryostat sections cut 
from each of the muscles from the injected legs and from the contralateral 
legs of five mice, were thawed onto slides coated with gelatin (0.5%) and 
chrome  alum (0.2%)  for  immunoltuoreseent visualization of dystrophin 
(Partridge et al., 1989). This gives a good indication of host/donor compo- 
sition of the muscle fibers local to the section (Karpati et al.,  1989; Par- 
tridge et al.,  1989). The serial cryosection was stained with haematoxylin 
and eosin for histological examination. 
After GPI isoenzyme analysis and dystrophin immunostaining, the re- 
maining portions of TA muscles removed 29-67 d after injection of wild- 
type nape,  mdx mpc, or medium alone were solubilized and total muscle 
protein was subjected to dystrophin immunoblotting (Hoffman et al., 1988). 
The immunoblot, after use for dystrophin detection, was reprocessed with 
mAb I)2 (Kaprielian and Fambrough,  1987) for detection of a fast twitch 
isoform of the Ca  2+ Mg  2+ ATPase, as a control for the muscle protein cow 
tent of each lane. 
Sections cut from three levels, 100 ~,m apart, of the para~n-embedded 
distal portions of the injected and contralateral muscles were stained with 
haematoxylin and eosin for routine histological analysis. The percentage of 
centrally nucleated fibers was counted on a section from the mid-zone of 
each muscle. The percentage of dystrophin-positive fibers was counted on 
the immunocytochemically stained section from each muscle. 
Detailed results from the analysis of TA, EDL,  and peroneus muscles 
injected with wild-type mpe and mdx rope are shown in Fig.  1. 
Results 
X-irradiated Muscles Injected with Culture Medium 
TA, EDL, and peroneus muscles of four mice were exam- 
ined at 29, 49 (two mice), and 67 d after injection of medium. 
Nonirradiated muscles of the left legs of these animals were 
of typical mdx appearance,  with many close-packed muscle 
fibers (a large proportion of which were centrally nucleated) 
and areas of necrosis and regeneration (Fig.  2, a  and b). 
Muscles of the right legs, which had been irradiated at 16 d 
and injected with culture medium at  19 d,  all showed the 
histopathological  features  of irradiated  mdx  muscles  de- 
scribed previously (Wakeford et al., 1990), with marked at- 
rophy  involving loss of muscle fibers (Fig.  3 a).  Necrotic 
fibers were seen, but there was no evidence of regeneration. 
The few surviving muscle fibers, only small proportions of 
which (0.5-3.6%) were centrally nucleated, were of large av- 
erage diameter and were separated  from one another  by a 
loose cellular connective tissue (Fig. 3 b). As expected, these 
muscles contained only host type GPI (Fig. 4). 
In  one  peroneus,  examined  at  49  d  after  injection  of 
medium,  a  group  of three  dystrophin-positive  fibers  was 
found; another, examined at 67 d after injection of medium, 
contained  one  dystrophin-positive  fiber.  These  sporadic, 
dystrophin-positive fibers occur in mdx muscles,  singly, or 
in clusters of up to four contiguous profiles, and are thought 
to  reflect  somatic  cell  mutation  (Hoffrnan  et  al.,  1990). 
These "revertant" positive fibers are found with a frequency 
in our mdx colony of much less than one profile per section 
of EDL, TA, or peroneus muscle and are not augmented by 
high doses of x rays,  so they do not interfere significantly 
with identification of positive fibers derived from injected 
normal mpc. 
On immunoblots of irradiated  TA muscles that had been 
injected  with medium  alone,  no  dystrophin  was  detected 
(Fig.  5). 
X-irradiated Muscles Injected with I~ld-73ype mpc 
Detailed results of the GPI isoenzyme analysis, dystrophin 
immunostaining, and degree of central nucleation of each in- 
dividual muscle are shown in Fig.  1 a. 
At 7 d after injection, host and donor, but no heterodirner 
GPI, were detected in the TA muscle, host alone being found 
in the EDL and peroneus muscles.  In the immunostained 
section of the  TA  (Fig.  6),  the  site of injection could be 
identified as a linear track of small, disoriented dystrophin- 
positive myotubes, surrounded by a solid zone of correctly 
oriented dystrophin-positive muscle fibers extending some 
200 ttm on either side of the injection track.  Comparison 
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Figure I. Summary of results 
on irradiated mdx muscles in- 
jected  with  mpc.  Numbers 
along  the  bottom  show the 
time elapsing between injec- 
tion of mpc and examination 
of the muscle.  At each time 
three muscles were examined: 
TA, peronei,  and  EDL. For 
each muscle, four results are 
indicated:  ([])  percent  GPI 
isomer  present  in the donor 
form; (~) percent GPI present 
in heterodimer form; (o) per- 
cent muscle fibers that  stain 
positive  for dystrophin;  and 
(1) percent muscle fibers con- 
taining centrally placed nuclei. 
(a) Muscles injected with nor- 
mal mpc; (b) muscles injected 
with mdx mpc. 
with the serial cryostat section stained with haematoxylin 
and eosin,  shows that this dystrophin-positive zone com- 
prised  both  peripherally  and  centrally  nucleated  muscle 
fibers, the latter predominating close to the injection site. 
Wax sections from the distal half of  the injected muscle again 
contained mainly peripherally nucleated muscle fibers, with 
a few centrally nucleated fibers located close to the injection 
site (Fig. 7). 
Considering these early stages as a whole, of  the nine mus- 
cles examined 7-14 d after injection of wild-type mpc, seven 
contained dystrophin-positive muscle  fibers.  Six of these 
contained  donor,  but  only  one  contained  a  significant 
amount of heterodimer GPI, suggesting that the implanted 
myogenic cells had mainly  formed new  muscle  fibers of 
purely donor origin.  Even by 10 d, in two muscles, these 
dystrophin-positive fibers, many of which were very small, 
comprised >60 % of the total muscle fibers. As in the TA ex- 
amined  7  d  after  mpc  injection,  the  dystrophin-positive 
fibers were predominantly located in one block surrounding 
a  small site of disturbed structure, the presumed injection 
site. 
In two muscles examined at 7 d after injection, small num- 
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mouse. This is the nonirradiated contralateral con- 
trol of the muscle shown in Figs. $ and 9. (a) Low 
power, showing closely packed muscle fibers with 
some areas of necrosis, inflammation, and regen- 
eration  (arrow).  Bar,  500 ~,m. (b) High power, 
showing a typical mdx myonecrotic lesion, with a 
small group of  necrotic fibers (arrow) and regener- 
ating fibers. The majority of  the fibers (67% in the 
muscle as a whole) contained centrally placed nu- 
clei. Paraffin section stained with hematoxylin and 
eosin.  Bar,  100/~m. 
bers of dystrophin-positive fibers but no donor or heterodi- 
trier  GPI were  found.  Conversely,  no  dystrophin-positive 
fibers were found at  10  d  in  one peroneus muscle which 
contained  some  donor  GPI.  We  can  only  explain  these 
findings by the fact that the sections used for the enzyme runs 
were made from a slightly different part of the muscle to that 
immunostained for dystrophin. This, in agreement with the 
lack  of  heterodimer  GPI,  suggests  that  the  dystrophin- 
positive fibers were very short and were not in cytoplasmic 
continuity with host muscle fibers at this stage. 
There was a sudden change in the pattern of regeneration 
between  14 and 21  d  after injection,  in that many mosaic 
fibers were formed. Analysis ofGPI isoenzyme in irradiated 
muscles examined from 21  to  67  d  after implantation of 
wild-type mpc showed that where donor cells were present, 
a variable proportion had become incorporated into the host 
muscle fibers,  for both donor and  heterodimer GPI were 
found in  14 out of 18 muscles examined. In many of these 
muscles the donor contribution,  in terms of GPI subunits 
(i.e., donor enzyme plus half the heterodimer), was 50% or 
more (Fig.  1). 
All of the muscles which contained donor, with or without 
heterodimer,  GPI also contained appreciable proportions, 
>70%  in some instances,  of dystrophin-positive fibers.  In 
general,  high proportions  of donor  and heterodimer GPI 
were associated with high proportions of dystrophin-positive 
fibers, but discrepancies were noted in individual muscles. 
These may reflect differences in the distribution of the two 
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leg of  this mouse had been X-irradiated 52 d previ- 
ously, and 3 d later culture medium only had been 
injected. (a) The magnification as Fig. 2 a, show- 
ing the massive atrophy of  the muscle, with overall 
loss  of  fibers  and loss  of  fascicular  structure.  Bar, 
500 ~m.  (b) High power. Most of the surviving 
fibers  are  periperally  nucleated,  rounded,  and 
separated from  each other by loose connective tis- 
sue.  There  is  some  necrosis  (arrow)  but  no 
regeneration.  Paraffin section stained with hema- 
toxylin and eosin.  Bar, 100/tm. 
markers  within  the muscle.  In  genetically  mosaic muscle 
fibers, dystrophin is often discontinuously distributed CKar- 
pati et al.,  1989; Partridge et al., 1989; Watldns et al., 1989) 
as is seen in parts of Fig. 8, indicating a degree of restriction 
to  territories  around  dystrophin-competent  myonuclei, 
whereas GPI isozyme subunits equilibrate freely along the 
length of the fibers (Frair and Peterson,  1983) and give an 
averaged estimate of muscle genotype. 
In muscles containing  a  high  proportion  of dystrophin- 
positive muscle fibers,  the  remaining  negative areas,  i.e., 
host mdx fibers that had survived since birth, were usually 
disposed in large compact blocks (Fig.  8). Within some of 
these blocks the occasional dystrophin-positive fiber could 
be seen (rather more than would be expected on the basis of 
somatic "reversion"), indicating that injected rope had proba- 
bly penetrated these regions. Transverse mid muscle sections 
of muscles which contained high proportions of dystrophin- 
positive fibers were much larger than irradiated muscles of 
equivalent  age that  had  been injected with medium  alone 
(compare Figs.  3 and 9). 
Between 21 and 49 d after injection, all muscles had a low 
proportion  (1.1-7.2%)  of centrally  nucleated  fibers.  Apart 
from occasional small loci of necrosis and regeneration, the 
fibers were closely packed, arranged in fascicles, and were 
virtually  indistinguishable  from  wild-type  mouse  muscle 
(Fig. 9, a  and b). The majority of centrally nucleated fibers 
seen in the hematoxylin- and eosin-stained frozen sections 
which could be identified with certainty on the dystmphin- 
stained sections were dystrophin positive. 
The three muscles from the mouse examined 67 d after in- 
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IEF, from cryostat sections  of the fol- 
lowing.  (Lane 1) Irradiated mdx nu/nu 
TA muscle, into which newborn C57Bl/ 
6J mpc had been implanted  10 d earlier. 
This muscle contained host and donor 
GPI  isoenzymes  only  and  contained 
dystrophin-positive  fibers.  (Lane 2) Ir- 
radiated  mdx  nu/nu  TA  muscle,  into 
which newborn C57B1/10 mpc had been 
implanted 29 d earlier. This muscle con- 
tained host, donor, and heterodimer GPI 
isoenzymes and  contained dystrophin- 
positive fibers. (Lane 3) Irradiated mdx nu/nu TA muscle, into which newborn C57B1/10 mpc had been implanted 49 d earlier.  This muscle 
contained host, donor, and heterodimer GPI isoenzymes and contained dystrophin-positive  fibers. (Lane 4) Irradiated mdx nu/nu TA mus- 
cle, into which newborn mdx mpc had been implanted  29 d earlier.  This muscle contained host, donor, and heterodimer GPI isoenzymes 
and contained no dystrophin-positive  fibers. (Lane 5) Irradiated mdx nu/nu TA muscle, into which newborn mdx mpc had been implanted 
67 d earlier. This muscle contained  host, donor, and beterodimer  GPI isoenzymes and contained  3.2% dystrophin-positive  fibers. (Lane 6) 
Control: a mixture of C57BI/6J and 129/ReJ skeletal  muscles,  to show that the AA and BB GPI isoenzymes do not reassociate  to form 
the heterodimeric AB GPI isoenzyme on lEE 
jection were particularly informative. Two of them, the EDL 
and TA, contained low proportions  of dystrophin-positive 
fibers,  but high proportions of centrally nucleated muscle 
fibers (17.7 and 10.7 %, respectively). The peroneus, by con- 
trast,  contained  a  high  proportion  of dystrophin-positive 
fibers  (67%)  and a  very low proportion (2%)  of centrally 
nucleated muscle fibers. 
Immunoblots of dystrophin from irradiated mdx TA mus- 
cles examined 29-67 d after implantation of wild-type mpc, 
revealed almost normal levels of this protein in all but one 
Figure 5.  Immunoblot detection of dystrophin in TA muscles. The gel was first processed for detection of dystrophin with antibody to 
the 60-kD dystrophin peptide.  Subsequently  it was reprocessed with a mAb to the fast muscle isoform of Ca  2+ Mg2+-ATPase, as a control 
for muscle protein loading.  (Lanes 1, 6, 14, and 19) Normal C57Bl/10  control TA muscle.  (Lane 2) Irradiated mdx nu/nu TA muscle, 
into which medium only had been implanted  32 d earlier.  (Lane 3) Irradiated mdx nu/nu TA muscle, into which newborn mdx mpc had 
been implanted 32 d earlier.  (Lane 4) Irradiated mdx nu/nu TA muscle, into which newborn C57B1/10 mix: had been implanted 32 d earlier. 
(Lanes 5, 13, and 18) mdx nu/nu TA muscle from an unlnjected contralateral  leg. (Lanes 7 and 8) Irradiated mdx nu/nu TA muscle, into 
which medium only had been implanted 52 d earlier.  (Lane 9) Irradiated mdx nu/nu TA muscle, into which newborn mdx mpc had been 
implanted 52 d earlier.  (Lanes 10-12) Irradiated mdx nu/nu TA muscle, into which newborn C57B1/10 mpc had been implanted 52 d earlier. 
(No muscle protein was present in the lane 10 sample.) (Lane 15) Irradiated mdx nu/nu TA muscle, into which medium only had been 
implanted  67 d earlier.  (Lane 16) Irradiated mdx nu/nu 1h muscle, into which newborn mdx mpc had been implanted  67 d previously. 
(Lane 17) Irradiated mdx nu/nu TA muscle, into which newborn C57B1/10 mpc had been implanted  67 d previously. Note: Only the TA 
muscles which had been injected after irradiation with normal mpc contained dystrophin. In most cases, this was present at close to normal 
levels. 
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mdx nu/nu  mouse.  This had 
been X  irradiated  at  16 d  of 
age,  and  4  d  later,  injected 
with 5  x  105 C57B1/6J  mpc. 
The muscle was removed 7 d 
after  implantation,  and  im- 
munostained  for  dystrophin. 
The  injection  site  is  clearly 
visible  (arrow) as  a  linear 
track  of  small  disoriented 
myotubes  surrounded  by  a 
zone  of  dystrophin-positive 
muscle  fibers.  The  dystro- 
phin-positive fibers seen found 
at a  distance of several hun- 
dred micrometers from the in- 
jection  site  (arrowhead) are 
more numerous than would be 
expected to occur by "rever- 
sion:  Cryostat  section,  (a) 
Low power. Bar, 500 ttm. (b) 
High power. Bar,  100 t~m. 
(Fig. 5, lane 17). The exception, examined 67 d after implan- 
tation,  contained no detectable dystrophin on the immuno- 
blot, few dystrophin-positive fibers, and only traces of donor 
and heterodimer GPI (Fig./),  indicating either that insuffi- 
cient mpc had been retained,  or that they had not thrived in 
the muscle. 
X-irradiated Muscles Injected with mdx mpc 
Muscles were examined from one mouse at 29, 49, and 69 d 
after injection of mdx mpc. The results are summarized in 
Fig.  1 b. All nine of the muscles examined from the injected 
right  legs  contained  host,  donor,  and  heterodimer  GPI. 
Morgan et al. Normal Myoblast Grafts Reconstitute mdx Muscles  2443 Figure 7. Wax section cut from distal half of the mus- 
cle shown in Fig. 6. This section contains part of the 
site of the injection of normal mpc. A few fibers close 
to this site are centrally nucleated but the majority are 
periperally nucleated. Stained with hematoxylin and 
eosin. Bar,  100 ~tm. 
Hgure 8. Low power dystrophin immunostain of a TA muscle of an mdx nu/nu mouse. This muscle had been X irradiated 52 d previously 
and injected 3 d later with 5  ×  1~C57B1/10 mpc. This shows the majority of the muscle, containing a large block of dystrophin-positive 
muscle fibers adjacent to a block of  dystrophin-negative  fibers. The blank area (arrow) is occupied by fibrous and fatty tissue and is presumed 
to be the injection site. Within the predominantly dystrophin-negative area axe several isolated dystrophin-positive fibers (arrowhead), 
more than we would expect to occur by reversion, suggesting that normal mpc have penetrated this region, but that the majority of mdx 
fibers in this  region have not yet degenerated. At the interface, some fibers (*) show dystrophin staining on the side facing their dystrophin- 
positive neighbors and no staining on the side facing their negative neighbors. This pattern of mosaicism suggests that the section is passing 
obliquely  through an interface between a dystrophin-positive  and dystrophin-negative  segment of these fibers. Cryostat section. Bar, 500 ~m. 
The Journal of Cell Biology,  Volume 111, 1990  2444 Figure 9. Hematoxylin and eosin stained wax section 
of the  muscle  shown  in  Fig.  8.  (a)  Low  power 
magnification,  showing that  the  muscle  contains 
closely packed muscle fibers, with areas of necrosis 
and  regeneration.  Bar,  500  tan.  (b)  High  power 
magnification of  area dose to the injection site. Apart 
from one or two centrally nucleated fibers (arrow), 
this muscle is histologically normal. Bar, 100 #m. 
There was  a  clear increase in contribution of donor GPI 
subunits with time in these muscles, implying a progressive 
displacement of the host component of these muscles by the 
implanted mdx mpe. 
At 29 d  after injection, all three muscles contained low 
proportions of centrally nucleated muscle fibers and, in this 
respect, were entirely comparable with muscles of equiva- 
lent age injected with wild-type mpc. At 49 and 67 d how- 
ever, there was a tendency to a higher level of central nuclea- 
tion, reaching 31 and 34 % of all fibers in two of the muscles 
examined at 67 d  after injection. Muscle bulk and muscle 
fiber number appeared even greater in mdx-injected muscles 
than in muscles of equivalent age injected with wild-type 
mpe. This preservation of muscle size and fiber number was 
particularly evident in the TA muscles 67 d after injection 
with mdx rope (Fig. 10, a and b). However, these older mus- 
cles exhibited all of the features of nontreated mdx muscles; 
i.e., abnormally shaped fibers, central nucleation, wide vari- 
ation in fiber size, fiber necrosis, and regeneration. 
In muscles of the oldest mouse, examined 67 d after injec- 
tion with mdx mpc, unusually large numbers of revertant 
dystrophin-positive fibers were seen (Fig.  1 b); seven in the 
TA, three in the EDL, and two in the peroneus. 
No dystrophin was  detected on immunoblots of the TA 
muscles into which mdx mpc had been injected (Fig.  5). 
Discussion 
How to reconcile  the mild clinical phenotype seen in the mdx 
mouse  with  the  unremitting  decline  in  muscle  function 
which characterizes DMD has been a subject of  much specu- 
lation. Two histological correlates of  the loss of  muscle func- 
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muscle had been X irradiated  71 d earlier and injected 
4  d  later with 5  ×  1@ mdx mpc.  (a) Low power, 
showing that  there  is good preservation of muscle 
bulk. Bar, 500/~m. (b) High power, showing features 
typical of mdx muscle; i.e., central nucleation (31%), 
a wide variation in fiber size, necrosis, and myotubes 
(arrow).  Paraffin section stained with hematoxylin 
and eosin. Bar,  100/~m. 
tion in DMD patients are (a) lack of effective muscle fiber 
regeneration and (b) massive fibrosis and fatty replacement 
of  muscle. These contrast with the modest increase in fibrous 
tissue (Marshall et al.,  1989) and spectacular regeneration 
seen in the mdx mouse. This inverse relationship between 
myogenesis and fibrosis has led to proposals that these two 
phenomena may be linked.  For instance, basic fibroblast 
growth factor, tending to stimulate mpc proliferation and to 
inhibit fibroblast proliferation, may provide a causal link, in- 
terspecies differences in the balance of these two effects be- 
ing held to account for the difference  between DMD and mdx 
(DiMario et al., 1989).  Equally, it seems likely that deposi- 
tion of  dense fibrous and fatty tissue interspersed between the 
muscle fibers in DMD might directly depress the effective- 
ness of myogenesis  by constraining cell movement and by di- 
minishing tissue perfusion. 
Other evidence suggests an intrinsic loss of proliferative 
capacity by myogenic cells in early DMD muscles (Blau et 
al.,  1983),  probably in consequence of enforced cycling of 
these cells in diseased muscle. In the present experiments, 
the endogenous regenerative powers of the resident myo- 
genic  cells  in  mdx  muscle  was  abolished  by  radiation 
(Wakeford et ai., 1990),  to provide an experimentally con- 
venient simulation of the  myofiber loss  which  occurs  in 
dystrophin-deficient DMD muscle. We cannot exclude the 
possibility that this high dose of radiation has additional 
effects on the muscle which may alter the ability of  implanted 
mpc to colonize it. However, this same radiation dose, ap- 
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detectable effect other than the predicted decrease in growth 
(Wakeford  et al.,  1990). 
By combined use of GPI markers, dystrophin immuno- 
staining, and standard histological sections, we have moni- 
tored the effects of implanting myogenic cells into irradiated 
mdx muscle. The extent to which wild-type mpc colonize 
preirradiated mdx muscles is a marked improvement over 
our previous studies where,  in nonirradiated regenerating 
mdx muscles, we found, at best, 30-40%  dystrophin-posi- 
tive fibers and 30--40 % of normal dystrophin levels on im- 
munoblots (Partridge et al.,  1989).  In the present study, 
preirradiated mdx muscles were far more extensively per- 
meated and replaced by implanted normal mpc;  in many, 
dystrophin-positive fibers comprised 60-80%  of the total 
and nearly normal levels of dystrophin were seen in the im- 
munoblots. More encouraging still, this high level of bio- 
chemical rescue was accompanied by retention or acquisi- 
tion  by  these  muscles  of  a  nearly  normal  histological 
phenotype.  Thus, rather perversely, the lack of myogenic 
potential of endogenous myogenic cells in muscles of DMD 
patients may actually enhance the efficacy of myoblast trans- 
fer therapy in this disease. 
This colonization of preirradiated mdx muscles by normal 
mpc appears to proceed in two stages. Up to 14 d after injec- 
tion of the mpc, donor isoenzyme was found in several mus- 
cles, usually in the absence of  heterodimer, implying that the 
numerous dystrophin-positive fibers present in these muscles 
were of purely donor origin. By contrast, from 21 d onward, 
heterodimer GPI was usually present in all muscles where 
donor GPI was found; in many cases the total donor contri- 
bution equaling or exceeding that of the host. Thus, there is 
a rapid transition from muscle fibers of purely donor origin 
to the formation of mosaic muscle fibers, with no evidence 
of further change after 21-29 d. It seems unlikely that these 
mosaic fibers could have formed by co-regeneration of host 
and donor mpc, since the radiation dose used reduces muscle 
fiber regeneration from endogenous mpc to the limits of de- 
tectability. Equally, normal muscle fiber growth, involving 
incorporation of donor mpc into host muscle fibers, can ac- 
count for few if any mosaic fibers, for the major phase of in- 
corporation of myoblasts into growing muscle fibers during 
growth should already have occurred by 35-40  d  of age 
(Cardasis and Cooper, 1975),  when we first find significant 
numbers of mosaic fibers. Moreover, previous attempts to 
achieve incorporation of injected myoblasts during muscle 
fiber growth, even in younger mice, have produced only low 
levels of mosaicism (Karpati et al., 1989; Watt et al., 1984; 
Morgan et al., 1988; Partridge et al., 1989). Rather, the my- 
ogenesis undertaken by the injected cells is probably as- 
sociated with the massive myonecrosis which occurs at this 
time in mdx muscle, irradiated or otherwise (Wakeford  et 
al., 1990), and which appears to be a most effective stimulus 
to mosaic fiber formation by injected myoblasts (Watt et al., 
1982; Morgan et al., 1988; Partridge et al., 1989). In the ab- 
sence  of endogenous  mdx  mpc,  mosaic  fibers  could be 
formed by fusion of donor mpc into the surviving segments 
of partly necrotic host muscle fibers or by fusion of the pure 
donor-derived myofibers formed during the first 14 d with 
segments of host muscle fiber.  In effect, therefore, the in- 
jected cells appear to repair degenerating host muscle fibers, 
a mechanism which has been presumed by others (Law et 
al.,  1990) but not critically tested. 
Analysis of dystrophin content by immunoblotting and by 
immunofluorescence confirms the picture of a progressive 
widespread replacement of  necrotic host muscle fibers by in- 
jected wild-type myogenic cells. Even by 7 d, dystrophin- 
positive fibers of purely donor origin are seen over a large 
proportion of the muscle, up to 200 #m from the presumed 
injection site,  implying a  very rapid lateral migration of 
these cells through the connective tissue components of the 
muscle. We do not attribute this to dispersal by passive car- 
riage in fluid under pressure from the injection, for, in other 
experiments, small particles of  tattoo dye incorporated in the 
cell  suspension remain closely associated with the  well- 
defined areas of tissue disruption we identify as injection 
sites.  These findings complement previous demonstrations 
of a rapid longitudinal movement of myogenic cells within 
regenerating muscle (Schultz et al.,  1985). 
Peronei were not deliberately injected with mpc, but most 
showed evidence of heavy infiltration by the implanted cells, 
suggesting that these cells had migrated in from injected 
neighbors. This accords with previous evidence of move- 
ment of mpc between muscles, as well as within them (Watt 
et al., 1987; Morgan et al., 1987) and gives encouragement 
to the cause of myoblast implantation therapy. However,  it 
is likely that mpc suspension had leaked out of the injected 
muscles and thus directly contacted the peroneus, but even 
then, they would have had to penetrate the peroneal epi- 
mysium. We can think of no irrefutable test of the more 
trivial explanation that we had injected mpc into the peronei 
by mistake, but hope that we would not make this error 
sufficiently often  to  account  for  the  consistency of our 
results. 
The sporadic, brightly dystrophin-positive fibers, found in 
irradiated mdx muscles which had been injected with either 
growth medium only, or with mdx mpc, are also of interest. 
Similar fibers found in untreated mdx muscle appear to con- 
tain essentially full-length dystrophin, probably  a  conse- 
quence of somatic mutations which restitute transcription of 
a functional message from the gene (Hoff-man et al., 1990). 
The finding of a much higher than normal number of such 
fibers in muscle of the oldest mouse injected with mdx mpc 
suggests that the proliferation of the injected mpc may lead 
to increased incidence of such somatic mutations. Whatever 
the basis, the occurrence of these fibers emphasizes the need 
for caution when analyzing the efficacy of myoblast transfer, 
particularly in human trials, where dystrophin may be the 
only marker of survival and incorporation of donor mpc into 
the host muscle fibers (Law et al.,  1990). 
Two incidental findings are of special interest in that they 
raise questions about the mechanisms of degeneration and 
regeneration in the mdx myopathy. First, dystrophin-nega- 
tive fibers are found in large distinct  blocks within the treated 
muscles. It is not clear why these surviving, peripherally 
nucleated fiber profiles should be so compactly grouped in 
irradiated muscles that had been injected with mpc, while 
the equivalent population of surviving mdx fiber profiles is 
diffusely distributed in muscle that had been irradiated but 
not injected with mpc. Perhaps the large block of  dystrophin- 
positive fibers formed adjacent to the injection site acts to 
protect this minor population of fibers furthest from the in- 
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them to degeneration and replacement by injected mpc. Al- 
ternatively, the surviving dystrophin-negative fiber profiles 
may be continuous with dystrophin-positive segments out of 
the plane of section. Certainly, dystrophin sometimes shows 
a segmental distribution (Karpati et al.,  1989; Partridge et 
al.,  1989), and some fibers in Fig.  8 appear to have been 
obliquely sectioned through a transition between dystrophin- 
positive and dystrophin-negative segments. The implication, 
that dystrophin may exert a protective effect on remote parts 
of the syncytial muscle fiber, runs counter to suggestions of 
local mechanical function for this molecule (Karpati et al., 
1989). 
The second point of interest,  is the rapid acquisition of a 
normal  peripherally  nucleated  appearance  by muscle  de- 
rived from injected mpc.  This is clearest where wild-type 
mpc had been injected; here GPI, and dystrophin immuno- 
blot and immunostaining all indicate that around half of the 
muscle  was  derived  from  the  injected  mpc,  but  only  a 
minority  of fiber  profiles  are  centrally  nucleated.  More 
directly, at 7 and 10 d after injection of wild-type mpc, most 
of the dystrophin-positive fibers, which GPI results tell us 
are derived entirely from donor mpc, were already peripher- 
ally nucleated. At 29-49 d after injection of wild-type mpc, 
centrally nucleated fibers never comprised >7 %. By 69 d, 
the most highly dystrophin-positive muscle contained only 
2 % centrally nucleated fibers whereas the two muscles with 
low incidences  of dystrophin-positive  fibers contained  10 
and  17% centrally nucleated fibers. 
It  is  difficult to  reconcile  this  data  with  the  long-term 
retention of centrally positioned myonuclei seen in regener- 
ated fibers in mouse muscle after grafting  (Partridge  and 
Sloper, 1977; Grounds et al.,  1980; Morgan et al.,  1989) or 
myonecrosis  in  the  mdx  mouse  (Bulfield  et  al.,  1984; 
Bridges, 1986; Carnwath and Shotton,  1987; Coulton et al., 
1988 a).  Together with an earlier observation of rapid pe- 
ripheral nucleation in regenerates of minced neonatal muscle 
(Grounds et al.,  1980),  it suggests the simple explanation 
that the developmental age of the myogenic cells determines 
whether  muscle  fibers  become  centrally  or  peripherally 
nucleated; neonatal mpc form fibers in which the myonuclei 
move rapidly to the periphery, older (3-wk) mpc form fibers 
where  the  myonuclei  remain  central.  A  similar  perinatal 
"maturation" of mouse myoblasts has been noted previously 
in vitro (Cossu et al.,  1983). 
The retention of peripheral nucleation up to 67 d by mus- 
cles  with  a  high  percentage  of dystrophin-positive  fibers, 
suggests that fusion of normal mpc into mdx fibers and con- 
sequent synthesis ofdystrophin may protect these fibers from 
subsequent degeneration. Two muscles, examined 67 d after 
injection,  which contained a low proportion of dystrophin- 
positive fibers also contained higher than usual proportions 
of  centrally  nucleated  fibers,  apparently  in  dystrophin- 
positive areas.  These muscles may have degenerated  late, 
and thus regenerated from older normal mpc that had lost 
their neonatal properties. 
Where mdx mpc were injected, dystrophin cannot be used 
as a marker, but the rapid proportional increase in donor and 
heterodimer GPI indicates that, here too, a significant pro- 
portion of the muscle fibers are of wholly donor or mosaic 
origin and have therefore been formed by regeneration. Again, 
central nucleation was initially low at 29 d, rising to 15 % 
at 49 d and, in two of three muscles, to >30% by 69 d. The 
gradual increase in central nucleation of muscle fibers pre- 
sumably reflects continuing  myonecrosis of fiber segments 
after implantation of mdx mpc. Interestingly, this rise occurs 
7-10 wk after injection (10-13 wk of age), whereas it might 
be expected to run on continuously from the time of injec- 
tion.  The reasons for this are currently being examined. 
The  continuing  degeneration/regeneration  in  irradiated 
muscle injected with mdx mpc is also manifested as a con- 
tinuous rise in donor and heterodimer GPI content over the 
67 d of observation. It contrasts with the rapid stabilization, 
by ~21  d,  of both GPI isoenzyme pattern and dystropbin 
content in mdx muscles injected with normal mpc. This rela- 
tive stability is the best evidence to date, although still cir- 
cumstantial,  for a functional benefit arising from dystrophin 
expression in dystrophic muscles treated by myoblast trans- 
fer. Together with the remarkable histological normalization 
of irradiated mdx muscle by injection of wild-type muscle 
precursor cells, it gives cause for optimism with regard to 
the use of myogenic cells for treatment of inherited myopa- 
thies.  It suggests that the paucity of effective host mpc in 
DMD (Blau et al., 1983) may be advantageous in encourag- 
ing the dispersion of injected mpc and it demonstrates that 
there is no need for effective host regeneration  in order to 
form mosaic fibers. In fact, in the mdx mouse, this lack of 
competition from host myogenic cells leads to a massive en 
bloc conversion of muscle fibers to dystrophin  positivity, 
showing that the injected wild-type mpc readily penetrate the 
potential structural barriers within skeletal muscle, the peri- 
mysial connective tissues ensheathing fascicles, the endomy- 
sial tissue within the fascicles, and the basement membranes 
surrounding  individual muscle fibers.  Further investigation 
of this model should reveal the limits of dispersion of myo- 
genic cells within degenerating skeletal muscle and whether 
myogenic cells obtained from different developmental stages 
of muscle differ in the efficiency with which they can restore 
or maintain  normal muscle histology and function. 
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